Search

everythinglearnresearchcommunity

for

Search:↓

A 3-year-old boy was diagnosed with a rare, non-scarring hair loss condition called temporal triangular alopecia.

Hair science has grown significantly, focusing on conditions like alopecia and improving treatments and techniques.

Temporal triangular alopecia usually starts in early childhood and treatment with Minoxidil has limited effectiveness.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Trichoscopy helps tell apart Lichen planopilaris and Frontal fibrosing alopecia from other hair loss conditions.

The woman has a type of scarring hair loss with red bumps around hair follicles.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

A woman's hair loss looked like a different condition due to her hairstyle, and treatment stopped further hair loss but didn't regrow hair.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Low-dose oral minoxidil can improve hair and eyebrow growth in frontal fibrosing alopecia.

A 14-year-old boy was diagnosed with a rare hair condition that may lead to hair thinning and has no known effective treatments.

A woman with frontal fibrosing alopecia experienced unusual hair growth after using a specific topical lotion.

The document concludes that a woman has both Frontal Fibrosing Alopecia and Lichen Simplex Chronicus, a previously unreported combination of conditions.

Scalp reduction gives the most natural result for significant crown baldness, despite potential complications, and a systematic approach to surgical hair restoration results in few complications and high graft survival.

Microneedling with platelet-rich plasma can improve different types of hair loss.

Postmenopausal women can experience hairline recession, affecting their quality of life, and more research is needed for treatments.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Some babies are born with alopecia areata, and a treatment with clobetasol propionate can regrow hair in half of the cases.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

A woman's unique dementia was misdiagnosed, a genetic mutation increases Parkinson's risk with age, and finasteride may help with Tourette syndrome.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Temporal hair loss relates to overall scalp hair loss in women.

Body-hair transplant successfully improved scarred areas and frontal hair density without visible chest scarring.

Alopecia is not a significant predictor of thyroid disease when age and sex are considered.

A woman's hair loss was initially misdiagnosed as scarring hair loss but was actually a treatable autoimmune hair loss.